Current treatment of paediatric HB is based on clinical risk stratification as, until recently, most tumours were diagnosed based on radiology and elevation of the tumour marker Alpha fetoprotein (AFP), with histology only being analysed following resection. This evidence concerns the gene AFP and hemoglobin measurement.